The absence of Mlkl or Ripk3 significantly reduced liver inflammation, steatosis, and fibrosis in aged male mice, supporting the role of necroptosis in age-associated MASLD. Here, MLKL is linked to metabolic dysfunction-associated steatotic liver disease.